Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
TargetMol | Tags Metabolism
ANGPTL
(5)
ATP Citrate Lyase
(15)
Acetyl-CoA Carboxylase
(33)
Aconitase
(2)
Acyltransferase
(146)
Adenosine Deaminase
(16)
AhR
(31)
Amino Acids and Derivatives
(1039)
Aminopeptidase
(74)
Amylase
(54)
Angiotensin-converting Enzyme (ACE)
(173)
Apolipoprotein
(9)
CETP
(17)
CPT
(5)
Calcium Channel
(635)
Carbonic Anhydrase
(243)
Casein Kinase
(166)
Cytochromes P450
(511)
DHFR
(66)
Decarboxylase
(7)
Dehydrogenase
(487)
Drug Metabolite
(596)
Endogenous Metabolite
(3337)
Epoxide Hydrolase
(58)
FAAH
(73)
FABP
(17)
FXR
(81)
Factor VIII
(7)
Factor VIIa
(6)
Factor Xa
(97)
Fatty Acid Synthase
(70)
GHR
(1)
GSNOR
(3)
Glucokinase
(71)
Glucosidase
(218)
Glutathione Peroxidase
(80)
Glyoxalase
(17)
HIF/HIF Prolyl-Hydroxylase
(213)
HMG-CoA Reductase
(70)
HSP
(273)
Hexokinase
(10)
Hydrogenase
(2)
Hydroxylase
(45)
IDO
(96)
Indoleamine 2,3-Dioxygenase (IDO)
(100)
Isocitrate Dehydrogenase (IDH)
(47)
LDL
(26)
LDLR
(15)
Lipase
(39)
Lipid
(51)
Liposome
(443)
Lipoxygenase
(200)
Liver X Receptor
(51)
MAGL
(63)
MAO
(108)
Mitochondrial Metabolism
(217)
N-Acetylglucosaminyltransferase
(1)
NADPH
(64)
NAMPT
(54)
NEDD4-1
(3)
NEDD8
(9)
NUDIX hydrolase
(2)
Neprilysin
(31)
PAI-1
(40)
PDE
(541)
PGK1
(3)
PKM
(47)
PPAR
(405)
Phosphatase
(462)
Phospholipase
(205)
Phosphorylase
(22)
Photosystem (PS)
(5)
Procollagen C Proteinase
(1)
Prolyl Endopeptidase (PREP)
(33)
RAR/RXR
(12)
REV-ERB
(11)
ROR
(100)
Reactive Oxygen Species
(809)
Reductase
(136)
Retinoid Receptor
(111)
SGK
(25)
Serine/threonin kinase
(91)
Stearoyl-CoA Desaturase (SCD)
(30)
Taste receptor
(6)
Thioredoxin
(2)
Transaminase
(3)
Transferase
(232)
Transketolase
(12)
UGT
(17)
Vitamin
(91)
Xanthine Oxidase
(75)
glycosidase
(66)
hCE
(2)
stilbene oxidase
(1)
transporter
(94)

glycosidase

Glycoside hydrolases (also called glycosidases or glycosyl hydrolases) catalyze the hydrolysis of glycosidic bonds in complex sugars. They are extremely common enzymes with roles in nature including degradation of biomass such as cellulose (cellulase), hemicellulose, and starch (amylase), in anti-bacterial defense strategies (e.g., lysozyme), in pathogenesis mechanisms (e.g., viral neuraminidases) and in normal cellular function (e.g., trimming mannosidases involved in N-linked glycoprotein biosynthesis). Together with glycosyltransferases, glycosidases form the major catalytic machinery for the synthesis and breakage of glycosidic bonds.

Miglitol
T152972432-03-2
Miglitol (BAY1099) is an alpha-Glucosidase Inhibitor with antihyperglycemic activity.
  • $42
In Stock
Size
QTY
TargetMol | Citations Cited
4-Methylumbelliferyl-α-D-Glucopyranoside
T8513417833-43-1
4-Methylumbelliferyl-α-D-Glucopyranoside (4MU-αGlc) is a pH-dependent α-glucosidase fluorometric substrate, a biomarker for Fabry and Pompe diseases, quantifying α-glucosidase activity in infant blood spots.
  • $31
In Stock
Size
QTY
Fagomine
TQ029853185-12-9
Fagomine (D-Fagomine) is a mild glycosidase inhibitor, an analog of 1-deoxynojirimycin (DNJ) with hypoglycemic activity, and Fagomine reduces intracellular reactive oxygen species (ROS) production and malondialdehyde (MDA) levels.
  • $199
7-10 days
Size
QTY
α-Glucosidase-IN-78
T204369
α-Glucosidase-IN-78 (Compound 12m) is a reversible competitive inhibitor of α-glucosidase (α-glucosidase) with an IC50 of 6.0 μM. Due to its blood sugar-lowering properties, α-Glucosidase-IN-78 is applicable in diabetes research.
  • Inquiry Price
Size
QTY
α-Glucosidase-IN-84
T205575
α-Glucosidase-IN-84 (Compound 7j) is a competitive inhibitor of α-glucosidase, exhibiting an IC50 of 50 μM and a Ki of 32 μM. It shows potential for application in metabolic disease research, particularly in studies related to type 2 diabetes.
  • Inquiry Price
Size
QTY
α-Glucosidase-IN-89
T206724
α-Glucosidase-IN-89 (8g) is an inhibitor of α-glucosidase, with an IC50 of 0.5 μM and a Ki of 0.46 μM.
  • Inquiry Price
Size
QTY
Panosialin wA
TN10984792162-72-2
Panosialin wA inhibits α,β-glucosidase and mannosidase enzymes, but does not exhibit inhibitory activity against the influenza virus. However, it has a mild antibacterial effect.
  • Inquiry Price
10-14 weeks
Size
QTY
Docosapentaenoic acid (22n-3) sodium
T2062252983837-44-9
Docosapentaenoic acid (22n-3) sodium is a component of phospholipids. It exhibits inhibitory activity against α-amylase and α-glucosidase, with IC50 values of 17 μg/mL and 22 μg/mL, respectively. Additionally, Docosapentaenoic acid 22n-3 sodium enhances cell viability and has mild anti-inflammatory effects.
  • Inquiry Price
10-14 weeks
Size
QTY
α-Amylase/α-Glucosidase-IN-19
T206992223505-23-5
α-Amylase/α-Glucosidase-IN-19 (compound 10) is a dual inhibitor of α-amylase and α-glucosidase, with an IC50 of 170.7 μM and 60.37 μM, respectively.
  • Inquiry Price
10-14 weeks
Size
QTY
2,3-Dihydrocalodenin B
TN11177
2,3-Dihydrocalodenin B (Compound 6) is a compound isolated from the small, red-glowing Knema tree (Knema globularia). It acts as a potent, non-competitive inhibitor of α-glucosidase and α-amylase, with IC50 values of 1.1 and 2.6 μM, respectively. This compound is applicable in diabetes research.
    Inquiry
    α-Glucosidase-IN-57
    T209503
    α-Glucosidase-IN-57 (Compound 10c) is a competitive, orally active α-glucosidase inhibitor with an IC50 of 0.180 μM and a Ki of 0.15 μM. It effectively reduces fasting and overall blood glucose levels in mice, making it suitable for antidiabetic research.
      Inquiry
      α-Glucosidase-IN-67
      T210381
      α-Glucosidase-IN-67 (compound 5k) is a potent inhibitor of α-glucosidase, exhibiting IC50 values of 0.31 µM for α-glucosidase and 4.51 µM for α-amylase. This compound shows potential for research in type 2 diabetes.
        Inquiry
        α-Amylase/α-Glucosidase-IN-15
        T210372
        α-Amylase/α-Glucosidase-IN-15 (compound 6C) is an orally active inhibitor of α-glucosidase (α-Glucosidase) and α-amylase (α-amylase), with IC50 values of 21 μM and 61 μM, respectively.
          Inquiry
          α-Amylase/α-Glucosidase-IN-12
          T209765
          α-Amylase/α-Glucosidase-IN-12 (compound 10k) is a dual inhibitor targeting α-glucosidase and α-amylase, with IC50 values of 34.52 nM and 24.62 nM, respectively. This inhibitor is designed based on [triazolo[4,3-b][1,2,4]triazine and holds potential for diabetes research.
            Inquiry
            α-Amylase/α-Glucosidase-IN-14
            T210057
            α-Amylase/α-Glucosidase-IN-14 is an orally bioactive inhibitor of α-amylase and α-glucosidase, with IC50 values of 45.53 μM and 27.73 μM, respectively.
              Inquiry
              α-Glucosidase-IN-65
              T209869
              α-Glucosidase-IN-65 (compound 5) is a Schiff base derivative of 3,4-dihydroxyphenylacetic acid. It acts as a potent α-glucosidase inhibitor with an IC50 of 12.84 μM.
                Inquiry
                α-Glucosidase-IN-48
                T209399
                α-Glucosidase-IN-48 (compound 9) is a potent inhibitor of α-Glucosidase, with an IC50 of 1.30 μM.
                  Inquiry
                  α-Glucosidase-IN-77
                  T203496
                  α-Glucosidase-IN-77 (Compound H7) is a non-competitive α-glucosidase inhibitor with an IC50 of 1.25 μM. It reduces blood glucose levels, improves glucose tolerance, regulates gut microbiota, and exhibits hepatoprotective effects in a mouse model of type 2 diabetes.
                  • Inquiry Price
                  Size
                  QTY
                  α-Glucosidase-IN-76
                  T203476
                  α-Glucosidase-IN-76 (Compound 4r) is an inhibitor of α-glucosidase, with an IC50 of 5.44 μM. It can clear ABTS+ free radicals, with a TEAC value of 0.49. Additionally, α-Glucosidase-IN-76 inhibits the proliferation of T24 bladder cancer cells, with an IC50 of 1.74 μM.
                  • Inquiry Price
                  Size
                  QTY
                  α-Glucosidase-IN-79
                  T204466
                  α-Glucosidase-IN-79 (Compound 4d9) is a non-competitive α-glucosidase inhibitor with an IC50 of 2.11 μM, demonstrating greater inhibitory potency than the existing α-glucosidase inhibitors Acarbose (IC50 of 327.0 μM) and HXH8r (IC50 of 15.32 μM). It exhibits no cytotoxicity on normal human liver cells (LO2) and shows good metabolic stability in rat plasma. α-Glucosidase-IN-79 holds promise for research in type 2 diabetes.
                  • Inquiry Price
                  Size
                  QTY
                  Galactostatin
                  TN10031107537-94-0
                  Galactostatin is an inhibitor of β-galactosidase.
                  • Inquiry Price
                  10-14 weeks
                  Size
                  QTY
                  MPO-IN-6
                  T209254
                  MPO-IN-6 (compound ADC) is an electrophilic agent with excellent antioxidant and anti-inflammatory properties. It acts as an inhibitor of myeloperoxidase (MPO), dipeptidyl peptidase-4 (DPP-4), and α-glucosidase (α-GD), with IC50 values of 10 μM, 31.02 μM, and 46.05 μM, respectively. MPO-IN-6 may serve as a potential cardiovascular protective agent.
                    Inquiry
                    α-Amylase/α-Glucosidase-IN-13
                    T209782
                    α-Amylase/α-Glucosidase-IN-13 (Compound 5d) is a dual inhibitor of α-amylase and α-glucosidase, and is useful in diabetes research.
                      Inquiry
                      α-Glucosidase-IN-46
                      T209013
                      α-Glucosidase-IN-46 is a potent inhibitor of α-glucosidase, with an IC50 of 26.0 μM. This compound is applicable in the research of Type 2 diabetes.
                        Inquiry